Patel Sandip I
- SEC CIK
- 0001843601
No open-market purchases or sales filed in the past year.
Current role at each company
- ATCH AtlasClear Holdings, Inc.CFO and General Counselas of Jul 16, 2026
- AKTX Akari Therapeutics PlcDirectoras of Dec 18, 2025
- PKBO Peak Bio, Inc.Directoras of Nov 18, 2024
- Quantum FinTech Acquisition CorpDirectoras of Feb 16, 2024
- MTRY Monterey Innovation Acquisition CorpDirector, 10% Owneras of Mar 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Patel Sandip I as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKTX Akari Therapeutics Plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)9:57 PM ET | Dec 16 | 2 days | Patel Sandip IDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +804.3K | $0.4041 | +$162.5K | –154.7K after | Derivative4 lots |
MTRY Monterey Innovation Acquisition Corp
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 (view filing)8:44 PM ET | Mar 9 | 4 days | Patel Sandip IDirector, 10% Owner | SSale | −570.0K | $0.006 | −$3.42K | −29.8%1.34M after |